
Dr Janine Trevillyan
@j_trevillyan
Infectious Diseases Physician, Clinical Virologist and HIV researcher. (she/her)
ID: 561645525
23-04-2012 23:47:02
383 Tweet
350 Followers
477 Following

Never a great start to reviewing a paper. "HIV/AIDS patients" belongs nowhere, least of all in the title of a submission to a journal. I'd encourage all journals to follow the lead of HIV Medicine & direct authors to the PeopleFirstCharter guidance. #languagematter #its2022FFS




Today we launched the National Antibiotic Allergy Network 🇦🇺 Inpatient Penicillin Allergy Database with the 1st patient entered in Austin Health! A great step forward to developing national data for #penicillinallergy. More sites around AUS coming! BioGrid Centre for Antibiotic Allergy & Research



Important work published in HIV Medicine showing the impact of non-communicable disease in PLHIV

Challenging Allergy - Drug Hypersensitivity Symposium #DHS2023 May 19th - 20th 2023 Doherty Institute Registrations open Monday 30th of Jan In-person and virtual options so all interested in #drugallergy #antibioticallergy can attend! eventbrite.com.au/e/challenging-…

Fantastic to get our THIRD #BOOSTICStudy site running today Monash Health, after a successful SIV at Austin Health last week. 🚂 With: Dr Janine Trevillyan Jillian Lau Zoe McQuilten Australasian Leukaemia & Lymphoma Group (ALLG) and A/Prof Bill Mulley TSANZ Infectious Diseases at Austin Health The Alfred Dept Infectious Diseases, The Alfred & Monash Uni Monash University



Amazing overview of #PENFAST opening session of ECCMID #ECCMID2023 by Jason Trubiano 🆔 now internationally validated. Score <3 very safe to delabel. Inc. special groups inpatients, ICH, NCIC NCAS_Australia . But not in kids yet and awaiting critical care group….



And that’s a wrap!! Thank you to all the Centre for Antibiotic Allergy & Research Austin Health Doherty Institute teams and our amazing speakers who made #DHS2023 such a success! 👏 👏 👏 Seen you again 😉


So excited to share our review paper just published in The Lancet Public Health on improving access to PrEP for international migrants. We must not leave them behind in the HIV response. MSHC Research @MonashCCS World Health Organization (WHO) rachel baggaley ASHM Health Equity Matters sciencedirect.com/science/articl…


Really looking forward to being part of this great session with AMAZING experts from around the world on what to do with those tricky ART decisions! ASHM IAS - the International AIDS Society Doherty Institute Infectious Diseases at Austin Health

After an amazing 24 hrs and a lot of #IDtwitter 🩷 I thought I would provide my thoughts on our PALACE Trial in JAMA Internal Medicine and how we got here! Direct oral challenge (DOC) vs. skin testing + oral challenge (SOC) for low-risk #penicillinallergy jamanetwork.com/journals/jamai… 1/4

Happening July 23rd – Join faculty members @tristanjbarber, Dr Janine Trevillyan, and colleagues in a virtual or live symposium about the latest strategies for individualizing ART management. You must be registered for IAS 2023 to attend. Register here: clinicaloptions.com/events/individ…

So honored to be part of this panel together with these fantastic women Dr. Aadia Rana MD and Dr. Carolyn Bolton Moore, chaired by Dr Janine Trevillyan and Dr. Anchalee Avihingsanon. Amazing questions and discussion. Thank you #IAS2023 IAS - the International AIDS Society for the opportunity ✨


Talk about global impact! Prof Lindsay Grayson representing AustinID World Health Organization (WHO) as a Senior Medical Advisor in Global Strategy on Infection Prevention and Control. Our registrar Dr Thorburn was in tow to listen, learn and document proceedings. Great work team!

I want to congratulate the scientific committee of #CROI2024: this is the first time I see (in more than 15 years) such a diverse, globally representative panel such as the one Clinical Cases in ART. Well done, dreamt session Conference of Opportunistic Infections Rajesh Gandhi
